These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29033275)

  • 1. Mechanisms of humoral immune response against Pseudomonas aeruginosa biofilm infection in cystic fibrosis.
    Mauch RM; Jensen PØ; Moser C; Levy CE; Høiby N
    J Cyst Fibros; 2018 Mar; 17(2):143-152. PubMed ID: 29033275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG avidity to Pseudomonas aeruginosa over the course of chronic lung biofilm infection in cystic fibrosis.
    Mauch RM; Nørregaard LL; Ciofu O; Levy CE; Høiby N
    J Cyst Fibros; 2018 May; 17(3):356-359. PubMed ID: 29032178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
    Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
    Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
    [No Abstract]   [Full Text] [Related]  

  • 8. Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.
    Jensen PØ; Kolpen M; Kragh KN; Kühl M
    APMIS; 2017 Apr; 125(4):276-288. PubMed ID: 28407427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
    Kobayashi H
    Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis.
    Smith DJ; Lamont IL; Anderson GJ; Reid DW
    Eur Respir J; 2013 Dec; 42(6):1723-36. PubMed ID: 23143541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of
    Bielen K; 's Jongers B; Boddaert J; Raju TK; Lammens C; Malhotra-Kumar S; Jorens PG; Goossens H; Kumar-Singh S
    Front Cell Infect Microbiol; 2017; 7():274. PubMed ID: 28680858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM; Monteiro R; Pereira MO
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
    Winkler U; Wingender J; Jäger KE
    Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of biofilm infections in cystic fibrosis patients.
    Høiby N; Bjarnsholt T; Moser C; Jensen PØ; Kolpen M; Qvist T; Aanaes K; Pressler T; Skov M; Ciofu O
    APMIS; 2017 Apr; 125(4):339-343. PubMed ID: 28407432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.